|
|
|
|
|
by rectang
2969 days ago
|
|
I wonder how widespread Lyme Disease has to get before the economic incentives to develop a new vaccine reach a tipping point. There used to be a vaccine but it was discontinued because of insufficient demand. https://www.niaid.nih.gov/diseases-conditions/lyme-disease-v... "In April 2002, GSK announced that even with the incidence of Lyme disease continuing to rise, sales for LYMErix declined from about 1.5 million doses in 1999 to a projected 10,000 doses in 2002." How do we square this with the number of cases rising so much over the last few years? |
|